ArticleFrontiers in cardiovascular medicine2025
Relationship between dynamic changes in remnant cholesterol and cardiovascular disease in middle-aged and older Chinese: a national cohort study.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between the remnant cholesterol and the risk of new-onset chronic diseases: evidence from CHARLS.Diabetology & metabolic syndrome · 2026Article
- Multi‑feature Prediction Model for Coronary Heart Disease Comorbidity in Middle‑aged and Older Adults with COPD Based on Machine Learning and SHAP.International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Epidemiological and genetic studies have shown that elevated basal remnant cholesterol (RC) levels increase cardiovascular disease (CVD) risk. However, the relationship between RC dynamics and CVD remains unclear. We aimed to investigate the relationship between the dynamic changes in RC and CVD occurrence in middle-aged and elderly populations in China. Methods and results: This cohort study investigated data from the study population of the 2011 and 2015 China Health and Retirement Longitudinal Study (CHARLS) and included 4,431 participants aged ≥45 years who provided complete information on RC and the occurrence or absence of CVD. Based on the change in RC in the population from 2011 to 2015, this study categorized the population into clusters 1, 2, and 3 using k-means cluster analysis. The relationship between baseline RC and CVD risk was examined using receiver operating characteristic (ROC) curves and restricted cubic spline (RCS) analysis. Logistic regression was used to explore the association between dynamic changes in RC levels and CVD risk, and subgroup analyses and sensitivity analyses were performed. There were 132 new cases of CVD among the 4,431 participants [2,386 women [53.85%] and 2,045 men [46.15%]; follow-up time, 4 years]. The area under the ROC curve for baseline RC in CVD was 0.534. RCS regression showed a linear association between RC at baseline and CVD. Logistic regression results showed a significantly increased CVD risk in Cluster 3 compared with Cluster 1 after correction for confounders (OR = 1.69, 95%CI: 1.13-2.55, Conclusions: In middle-aged and older Chinese participants, increased dynamic RC predicts increased CVD risk. Therefore, continuous monitoring of changes in RC levels is needed to reduce the risk of CVD. Lay summary: This cohort study, including 4,431 middle-aged and elderly Chinese individuals, found that dynamically elevated remnant cholesterol was significantly associated with a 1.69-fold higher cardiovascular disease incidence, suggesting that dynamically elevated remnant cholesterol predicts a higher risk of cardiovascular disease in China's middle-aged and elderly population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.